𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A lower dose of thalidomide is better than a high dose in metastatic renal cell carcinoma

✍ Scribed by Sandy Srinivas; Alice E. Guardino

Book ID
109051952
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
75 KB
Volume
96
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A pilot study of thalidomide in patients
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma
✍ Danai D. Daliani; Christos N. Papandreou; Peter F. Thall; Xuemei Wang; Cherie Pe πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

## Background: The highly vascular nature of renal cell carcinoma (rcc) suggests that angiogenesis inhibition may be therapeutic for patients with this disease. thalidomide inhibits basic fibroblast growth factor and vascular endothelial growth factor (vegf)-induced angiogenesis. ## Methods: In a

A Phase I trial of fixed dose rate gemci
A Phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma
✍ Brian I. Rini; Vivian Weinberg; Eric J. Small πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Metastatic renal cell carcinoma (RCC) has modest response rates to chemotherapy with gemcitabine and 5‐fluorouracil (5‐FU). Fixed dose rate gemcitabine infusion leads to enhanced intracellular accumulation of drug and possible augmented clinical effect. To determine the t